Fidelity Investments’s CalciMedica CALC Stock Holding History

Fidelity Investments’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-107	Closed	-$820	–	5401
2025 Q2	$820	Buy	+107	New	+$918	﹤0.01%	4987
2022 Q3	–	Sell	-11	Closed	-$1K	–	4886
2022 Q2	$1K	Hold	11	–	–	﹤0.01%	4676
2022 Q1	$1K	Sell	11 -1	-8%	-$95	﹤0.01%	4764
2021 Q4	$1K	Buy	+12	New	+$2.33K	﹤0.01%	4100
2021 Q3	–	Sell	-12	Closed	-$3.37K	–	4388
2021 Q2	$4K	Sell	12 -299	-96%	-$98.1K	﹤0.01%	3757
2021 Q1	$121K	Sell	311 -34,008	-99%	-$50.9M	﹤0.01%	2898
2020 Q4	$69.7M	Buy	34,319 +11,789	+52%	+$17.4M	0.01%	1188
2020 Q3	$20M	Buy	+22,530	New	+$23.5M	﹤0.01%	1563

Other funds holding CALC

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MPM

Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.93B AUM 16.26% 1-Year Est. Return

SSIM

Sheets Smith Investment Management Houston, Texas $154M AUM 66.97% 1-Year Est. Return

Fidelity Investments's CALC Position: Q3 2025 in Review

Fidelity Investments sold out of CalciMedica (CALC) in Q3 2025, closing a stake of 107 shares — an estimated $820 sold.

Fidelity Investments first reported a position in CALC in Q3 2020 and held it in 8 quarters. The position peaked at $69.7M in Q4 2020. 31 funds tracked by Wall St. Rank hold CALC as of Q3 2025.

Fidelity Investments reported no remaining CalciMedica position as of Q3 2025 after selling out during the quarter.
Fidelity Investments sold 107 CalciMedica shares in Q3 2025, an estimated $820.
Fidelity Investments first reported a position in CalciMedica in Q3 2020 and held it in 8 quarters.
Fidelity Investments's CalciMedica position peaked at $69.7M in Q4 2020.
31 funds tracked by Wall St. Rank held CalciMedica as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.